The purpose of this study is to evaluate the effect of Prostaglandin I2 analogue use on the
development of chronic allograft nephropathy and changes in allograft function in prevalent
renal transplant recipients
Drug: prostaglandin I2 analogue
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01056835
Ages eligible for Study
20 Years to 50 Years
Genders eligible for Study
Accepts Healthy Volunteers
prevalent renal transplant recipients 2 years after transplantation
no history of acute rejection
stable renal function
history of biopsy-proven chronic allograft nephropathy
history of biopsy-proven CNI nephrotoxicity
history of biopsy-proven or clinical acute rejection
unstable trough level of CNI or extremely low level of CNI
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.